effects [qlco]
Dydrogesterone [horm, phsu, strd]
Vascular System [bdsy]
Estrogens [horm, phsu, strd]
exert [orgf]
effects [qlco]
Vascular System [bdsy]
Progestogens [horm, phsu, strd]
Negative [qlco]
IMPACT [gngm]
g% [qnco]
Vasoconstrictor [phsu]
effects [qlco]
Arterial system [bdsy]
Contrast [qlco]
APPEAR [qlco]
To [qlco]
Neutral [qlco]
Markers, Biochemical [qlco]
Indirect [qlco]
Clinical Endpoint [clna]
Blood Pressure [orgf]
ACT [topp]
Surrogate Markers [qlco]
Vascular function [clna]
studies [lbpr]
Lipid [lipd]
Carbohydrate Metabolism [moft]
Vascular function [clna]
Addition [ftcn]
Attenuate [acty]
Estrogenic Effects [fndg]
Dydrogesterone [horm, phsu, strd]
Neutral [qlco]
effects [qlco]
Haemostasis [ortf]
Data [idcn]
Available [ftcn]
Clinical [qlco]
Parameters [fndg]
blood flow measurement [diap]
Women [popg]
Pre-Existing Diseases [rnlw]
CARDIOVASCULAR [bdsy]
Increased [qnco]
Risk [qlco]
Excluded [idcn]
Combination [qlco]
Estrogen Replacement [topp]
Further [spco]
studies [lbpr]
Focus [spco]
Open [spco]
Question [inpr]
Neutral [qlco]
properties [qlco]
Option [ftcn]
Including [ftcn]
Old [tmco]
Women [popg]
Increased [qnco]
CARDIOVASCULAR [bdsy]
Risk [qlco]
